Skip to main content
. 2006 Nov 10;63(5):548–561. doi: 10.1111/j.1365-2125.2006.02803.x

Table 3.

Population estimated model parameters and related information

PK/PD parameter Population mean [θ (SE for θ)] Interindividual variance (ω,% CV)
CLx/f (ml h−1)* 7.32 (0.153) 20.3
CLX/f exponent for body weight 0.911 (0.135)
ΔCLC/f (ml h−1) 5.86 (0.920) 34.9
CLE/f (ml h−1) 71.0 (4.68) 25.3
CLE/f exponent for baseline IgE −0.281 (0.0312)
PE/f (µg h−1) 30.3 (2.04) 23.1
PE/f exponent for baseline IgE 0.657 (0.0301)
 Correlation between η(CLE/f) and η(PE/f) 0.968
VX/f (ml)* 5900 (107) 13.0
VX/f exponent for body weight 0.658 (0.100)
VC/f (ml) 3630 (223) 25.0
ka (h−1) 0.0200 (0.00114) 39.9
Kd0 (nm) 1.07 (0.118)
α 0.157 (0.0306)
Intra-individual variance (σ,% CV)
Omalizumab 16.7
Total IgE 21.1
Free IgE 21.8

NONMEM objective function value: 37375.330. Total no. of observation records: 3192. Total no. of individuals: 202.

*

The value at 61.1 kg of body weight.

The value at 482.4 ng ml−1 of baseline IgE (30.3 µg h−1 = 0.159 nmol h−1).

VE/f was assumed to be the same as VX/f.